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Background: Posterior reversible encephalopathy syndrome is a potentially reversible clinicoradiologic syndrome
characterized by headache, mental confusion, visual disturbances and seizures associated with posterior cerebral
lesions on radiological imaging. Prompt treatment of this condition is mandatory to avoid severe irreversible
complications.
Case presentation: We report a 9-year-old boy with arterial hypertension and headache as unique clinical presentation
of posterior reversible encephalopathy syndrome.
Conclusions: Severe and isolated headache associated with arterial hypertension can be the unique clinical
presentation of posterior reversible encephalopathy syndrome. This syndrome must be considered even in absence of
all typical symptoms to prevent the progression of a potentially life threatening condition.
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Posterior reversible encephalopathy syndrome (PRES),
first described by Hinchey et al. in 1996 [1], is a clinicor-
adiological condition presenting with headache, seizures,
alterations of conscious level and loss of vision, accom-
panied by characteristic Magnetic Resonance Imaging
(MRI) findings. Both the neurological and radiolo-
gical features are potentially reversible [2]. Nevertheless
several complications as status epilepticus, intracranial
hemorrhage, and massive ischemic infarction have been
reported in association with this syndrome [3,4]. The re-
moval of the underlying causes is essential to prevent
long term sequelae [3,4].
We report a child with PRES presenting as hyperten-
sion and severe headache, with rapid clinical and neuro-
imaging normalization after a prompt treatment.* Correspondence: milani.gregoriop@gmail.com
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A previously normotensive 9-year-old boy was admitted
to the Pediatric Emergency Department with bilateral
periorbital edema and gross hematuria for 24 hours.
20 days before, he had experienced an episode of mild
sore throat spontaneously recovered.
On admission general conditions, neurological and vi-
sual examinations were normal except for periorbital ede-
mas. Axillary temperature was 36.9°C, oxygen saturation
98%, heart rate 88 beats per minute, body weight 35 kg
(two more than the previous week), and body height
1.350 m. Blood pressure was increased with systolic values
ranging between 125 and 130 mmHg and diastolic values
ranging between 80 and 85 mmHg (stage 1 hypertension:
95th percentile to the 99th percentile for gender, age, and
height plus 5 mmHg [5]). Blood and urine investigations
were consistent for acute renal insufficiency due to a
nephritic-nephrotic syndrome (Table 1).
Since the 2nd day of hospitalization, the patient was
treated with one bolus of methylprednisolone (15 mg/Kg)
per day associated with strict blood pressure monitoring.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Blood and urine exams on admission
Value Reference range
Blood exams
Red blood cells 4.2 x 106/mmc 3.9 – 5.2 x 106/mmc
Hematocrit 39% 34.5% - 42.5%
Hemoglobin 12.2 g/dL 10.5 - 14.5 g/dL
C-reactive protein 0.2 mg/dL < 0.5 mg/dL
pH 7.39 7.38 -7.42
Sodium 138 mEq/L 135-145 mEq/L
Potassium 4.0 mEq/L 3.5 – 5.0 mE/L
Ionized calcium 1.20 mmol/L 1.12 – 1.32 mmol/L
Creatinine 1.1 mg/dL < 0.7 mg/dL
Nitrogen urea 100 mg/dL 15 – 40 mg/dL
Albumin 3.0 g/dL 3.5 – 5.0 g/dL
Complement C3 17 mg/dL 86 – 184 mg/dL
Antistreptolysin titer 315 U/ml 0 – 200 U/ml
Urine exams
Protein/creatinin
ratio
3.5 mg/mg < 0.4 mg/mg
Red cells number 55 per high-power field < 5 per high-power
field
Hyaline casts on
sediment
Present Absent
Figure 1 Brain MRI cerebellar features. MRI fluid attenuated
inversion recovery (FLAIR) T2 images on axial (A) and coronal planes
(C) showing high signal intensities in cerebellar white matter
(indicated by the arrows). Follow up after 6 days showing a complete
resolution of the lesions on axial (B) and coronal planes (D).
Figure 2 Brain MRI parietal features. MRI fluid attenuated
inversion recovery (FLAIR) T2 images on axial (A) and coronal planes
(C) showing high signal intensities in parasagittal subcortical parietal
regions (indicated by the arrows). Follow up after 6 days showing a
complete resolution of the lesions on axial (B) and coronal planes (D).
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severe headache associated with increased blood pressure
up to 150/120 mmHg (stage 2 hypertension: > 99th per-
centile for gender, age and height plus 5 mmHg [5]).
Alterations of conscious level, visual symptoms and vomi-
ting were not present. Furthermore, cognitive dysfunc-
tions, visual field defects, sensory abnormalities and ataxia
were absent on the neurological examination.
A brain MRI showed in fluid attenuated inversion re-
covery imaging (T2 coronal) high signal intensities in
cerebellar white matter (Figure 1A and C) and in parasa-
gittal subcortical parietal regions (Figure 2A and C). Diffu-
sion weighted images did not show any restriction of
diffusivity.
Methylprednisolone was discontinued. Candesartan
was initiated and on 6th day of hospitalization, blood
pressure normalized and both headache and periorbital
edemas resolved. On 9th day of hospitalization, a control
MRI showed complete regression of all the abnormalities
(Figures 1B, D and 2B, D). Arterial hypertension, MRI
findings and clinical outcome were consistent with the
diagnosis of PRES.
The child was discharged in good clinical condition
without any further treatment.
3 weeks later, clinical examination was unremarkable
and blood pressure 105/70 mmHg. Complement C3 and
serum creatinine normalized and urinalysis revealed only
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high-power field).
Discussion
Posterior reversible encephalopathy syndrome has often
been reported in pediatric cases associated with hyper-
tension due to renal diseases or steroid treatment [3,6].
Symptoms usually include seizures, mental status
changes, visual alterations, headache and vomiting [6,7].
The literature describes posterior regions of the brain
being frequently involved, but concomitant anterior le-
sions are often detected. Brain stem, basal ganglia, deep
white matter, or splenium of the corpus callosum lesions
are also described in less than one third of the patients
[1,8]. The pathophysiology of this syndrome is not fully
understood, but appears to be multifactorial. The under-
lying mechanism could be a brain capillary leak syndrome
following hypertension, fluid retention or cytotoxic effects
of immunosuppressive agents on the vascular endothe-
lium. A sudden rise in blood pressure is probably the most
common cause. It can induce disruption of cerebral vascu-
lar auto-regulation, mostly in the posterior cerebral vascu-
lature, causing leakage of fluid into the brain parenchyma
[6-10]. Indeed a gradual blood pressure control is recom-
mended to avoid cerebral hypoperfusion and increased
morbidity [11].
Moreover this syndrome can be irreversible or even fatal
if an appropriate treatment is not started promptly [11].
Conclusions
To the best of our knowledge, severe and isolated head-
ache and hypertension have never been reported as
unique clinical presentation of PRES. We speculate that
the prompt recognition and treatment of this syndrome
prevented its progression to the full blown syndrome.
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